Why second opinions matter in breast cancer care—and how employers can help

Up to 43% of breast cancer diagnoses or treatment plans change with a second opinion. Most women never get one.

Breast cancer is one of the most common and complex health challenges employees can face. While early detection is crucial, what happens next isn’t always clear-cut. That’s where second opinions play a critical role.

Research shows that a second opinion may change the diagnosis or treatment plan in up to 43% of breast cancer cases. But a recent survey by the National Coalition for Cancer Survivorship (NCCS), uncovered that only 29% of patients sought a second opinion during their cancer care. Examples of common barriers include delay in treatment plans already in motion, trust in current providers, and lack of awareness—among many others.

For employers, creating awareness and simplifying access to second opinions help ensure employees get the right care from the start—leading to better outcomes, fewer unnecessary treatments, and lower long-term costs.

How AccessHope Is closing the gap with remote second opinions

Our employer-sponsored benefit gives your employees access to expertise solely focused on cancer—including breast cancer—without requiring them to switch doctors or leave their community of support.

• Expert multidisciplinary review: Each case is evaluated by subspecialists—each focused on a specific cancer type or subtype—from National Cancer Institute (NCI)-Designated Comprehensive Cancer Centers. These experts are immersed in the latest knowledge and advancements in cancer care, including genomic testing, targeted therapies, clinical trials, and breakthrough treatments. 
  
  
•  More than a written report: Unlike many expert medical opinion solutions that stop at a one-time written case review, AccessHope delivers a detailed report outlining evidence-based recommendations associated with improved clinical outcomes. These recommendations may include the latest cancer research findings and any suggested medications, treatments, tests, or clinical trials that may benefit the individual and their type of cancer. 
• Direct collaboration with the treating oncologist: Our specialists share recommendations with treating oncologists and offer to discuss findings and remain available for follow-up consultation throughout the episode of care. This collaborative model ensures your employees receive care informed by the most current knowledge and clinical guidelines without delay and at no additional cost to them.

Why it matters to your employees

Providing access to remote second opinions through AccessHope:

●    Helps confirm existing treatment plans and makes evidence-based recommendations.
●    Enables better outcomes, including quality of life and potential toxicities and side effects that come with treatment.
●    Reduces emotional stress for employees and their families
●    Drives long-term cost savings for the organization

At a time when employees expect more personalized support from their employers and their benefits, offering access to cancer expertise shows that you’re truly invested in their well-being—both at work and in life.